Eric Lefkofsky’s Tempus to provide Data to UChicago to help Battle Breast Cancer
The cancer-fighting startup was established by Eric Lefkofsky. Tempus initially wanted to help doctors at the University of Chicago with data to help come up with cancer treatment to help them treat breast cancer patients better.
Tempus announced a partnership with the University of Chicago Medicine to provide molecular sequencing and analysis to UChicago’s breast cancer specialists to create personalized treatment plans for patients.
Tempus believes data will help lead to better treatment and improved patient results.Breast cancer is the most prevalent of cancers. However, there is little information on its victims. The situation obligates several physicians to make hasty decisions without the specific genetic information that could help them make informed and precise decisions.
Tempus applies machine learning and genomic sequencing to assist the physician in making personalized treatment decisions. The startup was founded in 2015, with headquarters in Chicago, alongside Groupon, Drivin, and Lightbank.Tempus has partnered with several organizations, and Chicago is the latest in the recent past. Some of these partnerships include the Mayo Clinic.
About Eric Lefkofsky
Eric Lefkofsky is the co-founder of Lightbank and Tempus where he is also the CEO. Tempus is a massive technology company that has built a system to fight cancer. He also co-founded and Chairs Groupon.He and his wife Liza are co-chairs of the Lefkofsky Family Foundation. The foundation seeks to advance high-impact initiatives that promote the lives of others in the community.
Mr Eric is also a Trustee of Lurie Children’s Hospital of Chicago among others.He is an assistant professor at the University of Chicago. Erick has authored the book Accelerated Disruption: Understanding the True Speed of Innovation. He graduated from the University of Michigan and was awarded his Juris Doctor from the University of Michigan Law School..